Clinical Review Lesson of the week Celecoxib, rofecoxib, and acute temporary visual impairment BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7425.1214 (Published 20 November 2003) Cite this as: BMJ 2003;327:1214 Article Related content Metrics Responses Peer review Related articles This Week In The BMJ COX 2 inhibitors may cause temporary visual impairment Published: 20 November 2003; BMJ 327 doi:10.1136/bmj.327.7425.0-e See more Falsely elevated capillary glucose and ketone levels and use of skin lightening creams BMJ July 29, 2015, 351 h3879; DOI: https://doi.org/10.1136/bmj.h3879 The importance of the osmolality gap in ethylene glycol intoxication BMJ November 27, 2013, 347 f6904; DOI: https://doi.org/10.1136/bmj.f6904 Rhabdomyolysis after co-prescription of statin and fusidic acid BMJ October 09, 2012, 345 e6562; DOI: https://doi.org/10.1136/bmj.e6562 Cholestasis secondary to anabolic steroid use in young men BMJ February 02, 2012, 344 e468; DOI: https://doi.org/10.1136/bmj.e468 Amputation and intraosseous access in infants BMJ May 27, 2011, 342 d2778; DOI: https://doi.org/10.1136/bmj.d2778 Cited by... Role of the selective cyclo-oxygenase-2 (COX-2) inhibitors in childrenFulltext PDF
